Xenetic Biosciences, Inc. Intellectual Property Contracts & Agreements
7 Contracts & Agreements
- License Agreements (7 contracts)
- Exclusive License Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD (Filed With SEC on August 11, 2022)
- Exclusive License Agreement, dated December 20, 2021, between Lipoxen Technologies Limited and Public Joint-Stock Company Pharmsynthez (Filed With SEC on March 22, 2022)
- Novation of Agreement on Co-Development and the Terms of Exclusive License, dated December 17, 2021, between Xenetic Biosciences (UK) Limited (formerly Lipoxen plc), Lipoxen... (Filed With SEC on March 22, 2022)
- SIXTH AMENDMENT TO THE EXCLUSIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on April 15, 2014)
- DATED SEPTEMBER, 15 2010 LIPOXEN TECHNOLOGIES, LTD. - and - BAXTERHEALTHCARE CORPORATION AND BAXTER HEALTHCARE SA AMENDMENT NUMBER FIVE TO THE EXCLUSIVE RESEARCH, DEVELOPMENT AND... (Filed With SEC on April 15, 2014)
- DATED AUGUST, 10 2010 LIPOXEN TECHNOLOGIES, LTD. - and - BAXTERHEALTHCARE CORPORATION AND BAXTER HEALTHCARE SA AMENDMENT NUMBER FOUR TO THE EXCLUSIVE RESEARCH, DEVELOPMENT AND... (Filed With SEC on April 15, 2014)
- SECOND AMENDMENT TO EXCLUSIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on April 15, 2014)
